L453-0152 Screening compound: 4-[3-(2-{[(4-chlorophenyl)carbamoyl](methyl)amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-cyclohexylbenzamide

L453-0152 Screening compound: 4-[3-(2-{[(4-chlorophenyl)carbamoyl](methyl)amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-cyclohexylbenzamide
L453-0152 Screening compound: 4-[3-(2-{[(4-chlorophenyl)carbamoyl](methyl)amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-cyclohexylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L453-0152
4-[3-(2-{[(4-chlorophenyl)carbamoyl](methyl)amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-cyclohexylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L453-0152

Molecular Formula

C25H28ClN5O3 (C25 H28 ClN5 O3)

Compound Name

4-[3-(2-{[(4-chlorophenyl)carbamoyl](methyl)amino}ethyl)-1,2,4-oxadiazol-5-yl]-N-cyclohexylbenzamide

IUPAC name

4-[3-(2-{[(4-chlorophenyl)carbamoyl](methyl)amino}ethyl)-124-oxadiazol-5-yl]-N-cyclohexylbenzamide

SMILES

CN(CCc1noc(-c(cc2)ccc2C(NC2CCCCC2)=O)n1)C(Nc(cc1)ccc1Cl)=O

InChI

InChI=1S/C25H28ClN5O3/c1-31(25(33)28-21-13-11-19(26)12-14-21)16-15-22-29-24(34-30-22)18-9-7-17(8-10-18)23(32)27-20-5-3-2-4-6-20/h7-14,20H,2-6,15-16H2,1H3,(H,27,32)(H,28,33)

InChI Key

MRZGHVDWKIFZSA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27253105

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.98

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.850

Distribution Coefficient, logD

4.850

Water Solubility, LogSw

-4.83

Polar Surface Area

81.995

Acid Dissociation Constant (pKa)

11.69

Base Dissociation Constant (pKb)

-0.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

L453-0152 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

GABA Library (7115 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L453-0152 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L453-0152?
Check Price and Availability of L453-0152, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L453-0152 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L453-0152
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L453-0152
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L453-0152 available by request